Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Contribution of blocked potassium current conductance and increased conductance of persistent sodium current to the afterdischarge in myelinated neuron.

Wu SN, Lo YC, Chen BS, Cheung So E, Chen LT.

Muscle Nerve. 2012 Aug;46(2):297-9; author reply 300. doi: 10.1002/mus.23400. No abstract available.

PMID:
22806387
[PubMed - indexed for MEDLINE]
2.

A possible link of oxaliplatin-induced neuropathy with potassium channel deficit.

Dimitrov AG, Dimitrova NA.

Muscle Nerve. 2012 Mar;45(3):403-11. doi: 10.1002/mus.22311.

PMID:
22334175
[PubMed - indexed for MEDLINE]
3.

The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?

Park SB, Lin CS, Krishnan AV, Kiernan MC.

Cancer Chemother Pharmacol. 2011 May;67(5):1189-90; author reply 1191-2. doi: 10.1007/s00280-011-1579-y. Epub 2011 Feb 16. No abstract available.

PMID:
21327679
[PubMed - indexed for MEDLINE]
4.

Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.

Sittl R, Carr RW, Fleckenstein J, Grafe P.

Neurotoxicology. 2010 Dec;31(6):694-700. doi: 10.1016/j.neuro.2010.07.006. Epub 2010 Jul 27.

PMID:
20670646
[PubMed - indexed for MEDLINE]
5.

Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity.

Basso M, Modoni A, Spada D, Cassano A, Schinzari G, Lo Monaco M, Quaranta D, Tonali PA, Barone C.

Cancer Chemother Pharmacol. 2011 May;67(5):1179-87. doi: 10.1007/s00280-010-1466-y. Epub 2010 Sep 25.

PMID:
20872144
[PubMed - indexed for MEDLINE]
6.

Liability of the voltage-gated sodium channel gene SCN2A R19K polymorphism to oxaliplatin-induced peripheral neuropathy.

Argyriou AA, Antonacopoulou AG, Scopa CD, Kottorou A, Kominea A, Peroukides S, Kalofonos HP.

Oncology. 2009;77(3-4):254-6. doi: 10.1159/000236049. Epub 2009 Sep 7.

PMID:
19738391
[PubMed - indexed for MEDLINE]
7.

Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?

Antonacopoulou AG, Argyriou AA, Scopa CD, Kottorou A, Kominea A, Peroukides S, Kalofonos HP.

Eur J Neurol. 2010 Jul;17(7):963-8. doi: 10.1111/j.1468-1331.2010.02966.x. Epub 2010 Feb 23.

PMID:
20192979
[PubMed - indexed for MEDLINE]
8.

The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.

Carozzi VA, Marmiroli P, Cavaletti G.

Curr Cancer Drug Targets. 2010 Nov;10(7):670-82. Review.

PMID:
20578989
[PubMed - indexed for MEDLINE]
10.

[Ion channel dysfunction and peripheral nerve disorders].

Lefaucheur JP.

Rev Neurol (Paris). 2001 May;157(5):477-9. French. No abstract available.

PMID:
11438767
[PubMed - indexed for MEDLINE]
11.

Peripheral neuropathy induced by oxaliplatin-based chemotherapy.

[No authors listed]

J Support Oncol. 2006 Feb;4(2):82-3. No abstract available.

PMID:
16499128
[PubMed - indexed for MEDLINE]
12.

Current-clamp analysis of a time-dependent rectification in rat optic nerve.

Eng DL, Gordon TR, Kocsis JD, Waxman SG.

J Physiol. 1990 Feb;421:185-202.

PMID:
2348391
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Biophysical properties of the silent and activated rat sympathetic neuron following denervation.

Sacchi O, Rossi ML, Canella R, Fesce R.

Neuroscience. 2005;135(1):31-45.

PMID:
16084656
[PubMed - indexed for MEDLINE]
14.

The pain with platinum: oxaliplatin and neuropathy.

Kiernan MC.

Eur J Cancer. 2007 Dec;43(18):2631-3. Epub 2007 Oct 30. No abstract available.

PMID:
17977714
[PubMed - indexed for MEDLINE]
15.

Oxaliplatin, an anticancer agent that affects both Na+ and K+ channels in frog peripheral myelinated axons.

Benoit E, Brienza S, Dubois JM.

Gen Physiol Biophys. 2006 Sep;25(3):263-76.

PMID:
17197725
[PubMed - indexed for MEDLINE]
Free Article
16.

Exploration of platinum-induced neuropathy should be based on both objective and subjective examinations.

Oldenburg J, Fosså SD.

Acta Oncol. 2009;48(6):804-6. doi: 10.1080/02841860902984729. No abstract available.

PMID:
19484592
[PubMed - indexed for MEDLINE]
17.

Unified modeling of conductance kinetics for low- and high-conductance potassium ion channels.

Tolokh IS, Goldman S, Gray CG.

Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Jul;74(1 Pt 1):011902. Epub 2006 Jul 5.

PMID:
16907122
[PubMed - indexed for MEDLINE]
18.

The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy.

Argyriou AA, Polychronopoulos P, Chroni E.

Oncologist. 2007 Nov;12(11):1371-2; author reply 1372-3. No abstract available.

PMID:
18055858
[PubMed - indexed for MEDLINE]
Free Article
19.

Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.

Dunlap B, Paice JA.

J Support Oncol. 2006 Sep;4(8):398-9. No abstract available.

PMID:
17004514
[PubMed - indexed for MEDLINE]
20.

The case of the tingling toes.

Eisenberg S.

ONS Connect. 2011 Sep;26(9):17. No abstract available.

PMID:
21954796
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk